BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36706438)

  • 1. Ovarian Clear Cell Carcinoma and Markers of Epithelial-Mesenchymal Transition (EMT): Immunohistochemical Characterization of Tumor Budding.
    Lin LH; Zamuco RD; Shukla PS
    Int J Gynecol Pathol; 2023 Nov; 42(6):602-612. PubMed ID: 36706438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor budding of cervical squamous cell carcinoma: epithelial-mesenchymal transition-like cancer stem cells?
    Zheng S; Luo J; Xie S; Lu S; Liu Q; Xiao H; Luo W; Huang Y; Liu K
    PeerJ; 2022; 10():e13745. PubMed ID: 35860042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma.
    Luo W; Fang W; Li S; Yao K
    Int J Cancer; 2012 Oct; 131(8):1863-73. PubMed ID: 22307379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
    Umbreit C; Flanjak J; Weiss C; Erben P; Aderhold C; Faber A; Stern-Straeter J; Hoermann K; Schultz JD
    Anticancer Res; 2014 Dec; 34(12):7061-9. PubMed ID: 25503133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma.
    Angadi PV; Patil PV; Angadi V; Mane D; Shekar S; Hallikerimath S; Kale AD; Kardesai SG
    Int J Surg Pathol; 2016 Dec; 24(8):696-703. PubMed ID: 27312520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation.
    Chaw SY; Abdul Majeed A; Dalley AJ; Chan A; Stein S; Farah CS
    Oral Oncol; 2012 Oct; 48(10):997-1006. PubMed ID: 22704062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
    Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
    Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients.
    Lee SJ; Choi SY; Kim WJ; Ji M; Lee TG; Son BR; Yoon SM; Sung R; Lee EJ; Youn SJ; Park SM
    Diagn Pathol; 2013 Jun; 8():99. PubMed ID: 23783026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
    da Silva SD; Morand GB; Alobaid FA; Hier MP; Mlynarek AM; Alaoui-Jamali MA; Kowalski LP
    Clin Exp Metastasis; 2015 Jan; 32(1):55-63. PubMed ID: 25433796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
    Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
    J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-Mesenchymal Transition Markers β-catenin, Snail, and E-Cadherin do not Predict Disease Free Survival in Prostate Adenocarcinoma: a Prospective Study.
    Ipekci T; Ozden F; Unal B; Saygin C; Uzunaslan D; Ates E
    Pathol Oncol Res; 2015 Sep; 21(4):1209-16. PubMed ID: 26037169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
    Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
    Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of nuclear β-catenin accumulation in the Twist2-induced ovarian cancer EMT.
    Mao Y; Xu J; Li Z; Zhang N; Yin H; Liu Z
    PLoS One; 2013; 8(11):e78200. PubMed ID: 24244294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of E-cadherin, Beta-catenin, N-cadherin, ZEB1 and αSMA as Epithelial Mesenchymal Transition markers with prognostic factors in early and advanced stage laryngeal squamous cell carcinomas.
    Kucuk U; Ekmekci S; Talu CK; Pekcevik Y; Cukurova I
    Indian J Pathol Microbiol; 2023; 66(2):237-245. PubMed ID: 37077062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1, E-cadherin and beta-catenin expression in FIGO Stage IA cervical squamous carcinoma: diagnostic value and evidence for epithelial-mesenchymal transition.
    Koay MH; Crook M; Stewart CJ
    Histopathology; 2012 Dec; 61(6):1125-33. PubMed ID: 23190089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A switch from epithelial to mesenchymal properties correlates with lymphovascular invasion in squamous cell carcinoma of the penis.
    May M; Brookman-May S; Burger M; Koch S; Otto W; Bründl J; Albrecht K; Denzinger S
    Pathol Res Pract; 2015 Sep; 211(9):641-5. PubMed ID: 26092595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcomatoid renal cell carcinoma is an example of epithelial--mesenchymal transition.
    Conant JL; Peng Z; Evans MF; Naud S; Cooper K
    J Clin Pathol; 2011 Dec; 64(12):1088-92. PubMed ID: 22003062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Theoretical Model of the Wnt Signaling Pathway in the Epithelial Mesenchymal Transition.
    Gasior K; Hauck M; Wilson A; Bhattacharya S
    Theor Biol Med Model; 2017 Oct; 14(1):19. PubMed ID: 28992816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a.
    Wang S; Qiu M; Xia W; Xu Y; Mao Q; Wang J; Dong G; Xu L; Yang X; Yin R
    Oncotarget; 2016 Nov; 7(48):79736-79746. PubMed ID: 27806326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Budding, EMT and Cancer Stem Cells in T1-2/N0 Oral Squamous Cell Carcinomas.
    Attramadal CG; Kumar S; Boysen ME; Dhakal HP; Nesland JM; Bryne M
    Anticancer Res; 2015 Nov; 35(11):6111-20. PubMed ID: 26504037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.